# Effects of Dexmedetomidine on Breast Cancer Cell Function in Vitro

> **NCT03108937** · NA · COMPLETED · sponsor: **RenJi Hospital** · enrollment: 24 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT03108937
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-12
- **Primary completion:** 2017-07-07
- **Final completion:** 2017-09-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108937, "Effects of Dexmedetomidine on Breast Cancer Cell Function in Vitro". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03108937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*